Related Experiment Video
Updated: Feb 4, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR
1Department of Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. qycsuaqeeqimccse@sina.com.
Objective:
Mammalian target of rapamycin (mTOR) can negatively regulate cell autophagy, while its expression and activity are associated with the pathogenesis of osteosarcoma. MicroRNA 100 (MiR-100) down-regulation is associated with the pathogenesis and chemo-sensitivity of osteosarcoma. Bioinformatics analysis revealed the targeted relationship between miR-100 and the 3'-UTR of mTOR. We investigate the role of miR-100 in affecting mTOR expression, osteosarcoma cell autophagy, and sensitivity to cisplatin.
Patients And Methods:
MiR-100, mTOR, and Beclin-1 expressions in osteosarcoma tissue and normal control were compared. The relationship between miR-100 and mTOR was verified by dual luciferase assay. MiR-100, mTOR, and Beclin-1 levels in MG-63 cells and MG-63/DDP cells were tested. Cell apoptosis was determined by using flow cytometry. Cell malignancy was evaluated by colony formation assay.
Results:
MiR-100 and Beclin-1 significantly declined, while mTOR significantly increased in osteosarcoma tissue compared with that of normal tissue (p<0.05). MiR-100 targeting significantly inhibited mTOR expression compared to that of untreated (p<0.05). MiR-100 expression was down-regulated and mTOR level was elevated in MG-63/DDP cells compared with MG-63 cells (p<0.05). MG-63/DDP cells exhibited reduced cell autophagy and apoptosis, and enhanced colony formation induced by DDP. MiR-100 mimic and/or small interfere mTOR (si-mTOR) significantly promoted Beclin-1 expression, cell autophagy, and cell apoptosis, while attenuated colony formation.
Conclusions:
MiR-100 declined, while mTOR up-regulated in osteosarcoma tissue. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin via targeted inhibiting of mTOR.
Insights
MicroRNA 100 (MiR-100) is down-regulated in osteosarcoma, leading to increased mTOR expression. Restoring MiR-100 enhances autophagy and apoptosis, improving cisplatin sensitivity in osteosarcoma cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Mammalian target of rapamycin (mTOR) negatively regulates autophagy and is implicated in osteosarcoma pathogenesis.
- MicroRNA 100 (MiR-100) down-regulation is linked to osteosarcoma development and chemo-resistance.
Purpose of the Study:
- To investigate the role of MiR-100 in regulating mTOR expression.
- To determine the effect of MiR-100 on osteosarcoma cell autophagy and cisplatin sensitivity.
Main Methods:
- Comparative analysis of MiR-100, mTOR, and Beclin-1 expression in osteosarcoma and normal tissues.
- Dual luciferase assay to confirm the targeting relationship between MiR-100 and mTOR.
- Assessment of cell autophagy, apoptosis, and malignancy in MG-63 and MG-63/DDP cells following MiR-100 mimic or si-mTOR treatment.
Main Results:
- Osteosarcoma tissues showed decreased MiR-100 and Beclin-1, and increased mTOR compared to normal tissues.
- MiR-100 directly inhibited mTOR expression.
- MiR-100 mimic and/or si-mTOR treatment increased Beclin-1, autophagy, and apoptosis, while reducing colony formation in osteosarcoma cells.
Conclusions:
- MiR-100 is downregulated in osteosarcoma, correlating with elevated mTOR.
- Upregulating MiR-100 enhances cisplatin-induced autophagy and apoptosis by targeting mTOR.
- MiR-100 represents a potential therapeutic target for improving osteosarcoma treatment.
Related Concept Videos
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
GTPases and their Regulation
Large G-proteins,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
Negative Regulator Molecules

